165ug Lsd gel tabs

Descripción Del Producto

Lysergic Acid Diethylamide (LSD-25) is a semisynthetic ergoline derivative characterized by an indole core, a tetracyclic ring system, and a diethylamide moiety. In forensic science and chemical profiling, standardized 165 µg gelatin matrix formulations serve as precise analytical benchmarks for chromatographic calibration, structural characterization, and quantitative evaluation of seized psychoactive substances. The encapsulated gelatin carrier mitigates thermal and ultraviolet degradation, ensuring reproducible recovery rates during laboratory extraction.

Chemical & Pharmacodynamic Properties

• Chemical Formula & Molecular Mass: $\text{C}_{20}\text{H}_{25}\text{N}_{3}\text{O}$ | 323.44 g/mol

• Receptor Affinity & Target Profile: Functions primarily as a high-affinity agonist and partial agonist at central serotonin receptor subtypes—predominantly $5\text{-HT}_{2\text{A}}$, $5\text{-HT}_{2\text{C}}$, y $5\text{-HT}_{1\text{A}}$—alongside significant binding affinity for dopamine ($\text{D}_1$, $\text{D}_2$) and trace amine-associated receptors.

• Analytical Matrix Characterization: Formulated inside a purified gelatin matrix to ensure homogenous distribution of microgram-level active analyte, facilitating standardized peak integration in liquid chromatography-tandem mass spectrometry ($\text{LC-MS/MS}$) and gas chromatography-mass spectrometry ($\text{GC-MS}$).

• Presumptive Reagent Verification: Serves as a qualitative control to calibrate colorimetric transition thresholds using Ehrlich’s reagent (p-dimethylaminobenzaldehyde) and Hofmann’s reagent for indole detection.

Safety, Toxicity & Legal Compliance

• Strict Forensic / In Vitro Use: Designated strictly for certified academic institutions, forensic toxicology departments, and accredited reference testing laboratories.

• Toxicity & Physiological Risks: Uncontrolled systemic exposure in humans triggers acute autonomic activation (marked mydriasis, tachycardia, arterial hypertension, hyperthermia) and profound, prolonged disruption of sensory processing and cognitive function, posing risks of acute psychological distress and behavioral toxicity.

• Regulatory Classification: LSD is classified as a Schedule I controlled substance under the United States Controlled Substances Act, a Class A drug in the United Kingdom, and an internationally controlled substance under Schedule I of the UN 1971 Convention on Psychotropic Substances. Acquisition, storage, and chain-of-custody must comply fully with national regulatory licensing and DEA storage protocols.